| 12.12.2024 10:40 | N4P, VEL, VANL | AIM WINNERS & LOSERS: Velocity Composites expects to beat market view | Alliance |
| 04.12.2024 10:57 | N4P, BIOM, LIT | AIM WINNERS & LOSERS: Biome warns on revenue; legal blow for LCM | Alliance |
| 04.12.2024 07:00 | N4P | New Patent Filing | RNS |
| 28.11.2024 07:00 | N4P | Grant of Options | RNS |
| 01.11.2024 07:00 | N4P | N4 Pharma CEO Q&A Now LIVE | Reach |
| 24.10.2024 07:00 | N4P | New Corporate Presentation | Reach |
| 24.09.2024 15:01 | N4P, GWI, MET1 | EARNINGS: Metals One advances Black Schist, N4 generates revenue | Alliance |
| 24.09.2024 07:00 | N4P | Interim Results | RNS |
| 17.09.2024 08:04 | N4P | SRI Research Update | RNS |
| 09.09.2024 07:00 | N4P | Director Appointment | RNS |
| 23.08.2024 08:30 | N4P | Change of Auditor | RNS |
| 20.08.2024 11:52 | N4P | IN BRIEF: N4 Pharma celebrates chemistry work update on Nuvec | Alliance |
| 20.08.2024 10:24 | N4P, MBO, SKA | AIM WINNERS & LOSERS: Shuka Minerals down on CLN drawdown | Alliance |
| 20.08.2024 07:00 | N4P | SRI Research Update | RNS |
| 03.07.2024 12:09 | SQZ, GOOD, N4P | TRADING UPDATES: Topps Tiles sales dip; Physiomics completes placing | Alliance |
| 03.07.2024 07:00 | N4P | Nanogenics Update | RNS |
| 28.06.2024 07:00 | N4P | Total Voting Rights | RNS |
| 19.06.2024 07:00 | N4P | Holding(s) in Company | RNS |
| 18.06.2024 12:34 | N4P | Holding(s) in Company | RNS |
| 13.06.2024 16:52 | N4P | Holding(s) in Company | RNS |
| 11.06.2024 11:16 | N4P | New Corporate Presentation | Reach |
| 07.06.2024 12:32 | N4P | N4 Pharma raises GBP630,000 to advance primary work streams | Alliance |
| 07.06.2024 10:18 | N4P | Placing and Subscription to raise £630,000 | RNS |
| 23.05.2024 16:09 | N4P | Holding(s) in Company | RNS |
| 23.05.2024 12:19 | N4P | Result of AGM | RNS |
| 16.05.2024 15:46 | SHC, SXS, STG | UK shareholder meetings calendar - next 7 days | Alliance |
| 29.04.2024 10:59 | N4P | Posting of Annual Report & Notice of AGM | RNS |
| 26.04.2024 07:00 | N4P | N4 Pharma Webinar on SRI Collaboration | Reach |
| 25.04.2024 11:56 | N4P | N4 Pharma strikes partnership deal for intracellular delivery | Alliance |
| 25.04.2024 07:38 | N4P | Collaboration Agreement with SRI International Inc | RNS |
| 23.04.2024 13:32 | N4P | IN BRIEF: N4 Pharma loss widens but "great optimism" remains | Alliance |
| 23.04.2024 07:00 | N4P | Final Results | RNS |
| 18.04.2024 12:14 | N4P | N4 Pharma sees potential in Nuvec delivery method for cancer treatment | Alliance |
| 18.04.2024 07:00 | N4P | Oral Delivery Update | RNS |
| 04.03.2024 15:13 | N4P | Holding(s) in Company | RNS |
| 29.02.2024 07:00 | N4P | Holding(s) in Company | RNS |
| 15.02.2024 12:06 | N4P | IN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec research | Alliance |
| 15.02.2024 10:52 | DSW, SAR, N4P | AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets | Alliance |
| 15.02.2024 07:00 | N4P | in-vitro siRNA update | RNS |
| 19.01.2024 09:26 | N4P | IN BRIEF: N4 Pharma gets India patent for medical delivery system | Alliance |
| 19.01.2024 07:00 | N4P | Patent Grant | RNS |
| 18.01.2024 10:15 | N4P | Holding(s) in Company | RNS |
| 16.01.2024 13:26 | N4P | IN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105 | Alliance |
| 16.01.2024 07:00 | N4P | Nanogenics Update | RNS |
| 08.01.2024 16:24 | N4P | Holding(s) in Company | RNS |
| 08.01.2024 09:11 | N4P | N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8 | Alliance |
| 08.01.2024 07:00 | N4P | AAV Viral Vector Update | RNS |
| 18.12.2023 12:43 | N4P | N4 Pharma rises on successful results from Nuvec administration | Alliance |
| 18.12.2023 07:00 | N4P | Oral Delivery Update | RNS |
| 07.12.2023 18:28 | RNEW, SFT, N4P | TRADING UPDATES: N4 Pharma hails "encouraging" siRNA research | Alliance |
| 07.12.2023 11:28 | N4P | Holding(s) in Company | RNS |
| 07.12.2023 07:00 | N4P | Nuvec® R&D and Strategy Update | RNS |
| 01.12.2023 14:29 | SOLG, KDNC, PRTC | TRADING UPDATES: N4 launches investor hub; Capricorn production falls | Alliance |
| 30.11.2023 09:00 | N4P | N4 Pharma Launches New Interactive Investor Hub | Reach |
| 31.10.2023 07:00 | N4P | Total Voting Rights | RNS |
| 09.10.2023 07:00 | N4P | Investor Presentation via Investor Meet Company | Reach |
| 03.10.2023 08:15 | N4P | Holding(s) in Company | RNS |
| 02.10.2023 07:00 | N4P | Investor Presentation | Reach |
| 28.09.2023 10:20 | N4P | N4 Pharma shares fall as places shares to fund Nanogenics stake buy | Alliance |
| 28.09.2023 07:00 | N4P | Acquisition of Controlling Interest in Nanogenics | RNS |
| 12.09.2023 13:43 | N4P | N4 Pharma interim loss narrows slightly as business outreach ongoing | Alliance |
| 12.09.2023 07:00 | N4P | Interim Results | RNS |
| 25.07.2023 10:12 | N4P | N4 Pharma shares soar on further patent grant for Nuvec in US | Alliance |
| 25.07.2023 10:04 | PIER, AFRN, N4P | AIM WINNERS & LOSERS: N4 Pharma shares jump on grant of US patent | Alliance |
| 25.07.2023 07:00 | N4P | Patent Grant and Board Change | RNS |
| 27.06.2023 12:13 | N4P | IN BRIEF: N4 Pharma expands Professor Yu partnership on grant award | Alliance |
| 27.06.2023 07:00 | N4P | Grant Award for Professor Chengzhong Yu | Reach |
| 25.04.2023 16:19 | GILD, LGRS, N4P | TRADING UPDATES: Eckoh expects profit up; LXi REIT refinances facility | Alliance |
| 25.04.2023 10:30 | N4P, ECK, SML | AIM WINNERS & LOSERS: FireAngel 2023 earnings below expectations | Alliance |
| 25.04.2023 07:00 | N4P | siRNA update | RNS |
| 18.04.2023 14:20 | JNEO, BIOM, TLY | TRADING UPDATES: Journeo extends contract; Biome completes fundraise | Alliance |
| 18.04.2023 07:00 | N4P | siRNA update | RNS |
| 03.04.2023 14:11 | N4P | Result of AGM | RNS |
| 27.03.2023 15:50 | TRCS, RNWH, N4P | UK earnings, trading statements calendar - next 7 days | Alliance |
| 09.03.2023 14:32 | TLOU, SSIT, N4P | EARNINGS SUMMARY: Franchise Brands blooms; Tlou Energy loss widens | Alliance |
